|
|||||
![]() |
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter![]() |
Ticker | Owner | Relationship | Date | Transaction | Cost ![]() |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ICE | Kapani Mayur | Chief Technology Officer | Jun 13 '25 | Option Exercise | 50.01 | 5,662 | 283,157 | 79,875 | Jun 17 04:30 PM |
ICE | Kapani Mayur | Chief Technology Officer | Jun 13 '25 | Sale | 178.65 | 9,973 | 1,781,678 | 69,902 | Jun 17 04:30 PM |
ICE | MAYUR KAPANI | Officer | Jun 13 '25 | Proposed Sale | 179.08 | 9,973 | 1,785,965 | Jun 13 04:45 PM | |
ICE | Kapani Mayur | Chief Technology Officer | Mar 14 '25 | Option Exercise | 50.01 | 5,662 | 283,157 | 84,186 | Mar 17 04:30 PM |
ICE | Kapani Mayur | Chief Technology Officer | Mar 14 '25 | Sale | 170.52 | 9,973 | 1,700,575 | 74,213 | Mar 17 04:30 PM |
ICE | MAYUR KAPANI | Officer | Mar 14 '25 | Proposed Sale | 169.14 | 9,973 | 1,686,833 | Mar 14 04:26 PM | |
ICE | Kapani Mayur | Chief Technology Officer | Jan 15 '25 | Option Exercise | 50.01 | 5,661 | 283,107 | 72,209 | Jan 17 04:30 PM |
ICE | Kapani Mayur | Chief Technology Officer | Jan 15 '25 | Sale | 147.59 | 5,661 | 835,503 | 66,548 | Jan 17 04:30 PM |
ICE | MAYUR KAPANI | Officer | Jan 15 '25 | Proposed Sale | 145.25 | 5,661 | 822,260 | Jan 15 04:21 PM | |
ICE | Kapani Mayur | Chief Technology Officer | Nov 26 '24 | Option Exercise | 50.01 | 1,995 | 99,770 | 66,466 | Nov 27 04:30 PM |
ICE | Kapani Mayur | Chief Technology Officer | Jul 08 '24 | Option Exercise | 41.59 | 395 | 16,428 | 64,866 | Jul 10 04:31 PM |
ICE | Kapani Mayur | Chief Technology Officer | Jul 08 '24 | Sale | 141.13 | 395 | 55,746 | 64,471 | Jul 10 04:31 PM |
ICE | Kapani Mayur | Chief Technology Officer | Jul 02 '24 | Option Exercise | 41.59 | 400 | 16,636 | 64,871 | Jul 03 04:30 PM |
ICE | Kapani Mayur | Chief Technology Officer | Jul 02 '24 | Sale | 140.00 | 400 | 56,000 | 64,471 | Jul 03 04:30 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite